from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2190c/-

LFCtreatmentdescriptionclass of inhibitor

-0.232

Amikacinug/mL Amikacintranslation

0.001

Cap5-10ug/mL Capreomycintranslation

-0.292

Rox10-50 ug/mL Roxithromycintranslation

1.401

SM2-5 ug/mL Streptomycintranslation

0.766

Tet5-10 ug/mL Tetracyclinetranslation

0.245

Rif0.2-5ug/mL Rifampicintranscription

0.173

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.672

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.749

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.794

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.790

Clofazimine10-13 ug/mL Clofaziminerespiration

0.268

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.354

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.453

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.004

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.241

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.901

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.381

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.156

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.631

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.703

KCN5-20 ug/mL Potassium cyaniderespiration

-0.255

NaN30.2-2 mM Sodium aziderespiration

1.363

Nigericin50 uM Nigericinrespiration

-0.472

TRC10-150 ug/mL Triclosanrespiration

-2.609

TRZ10-25 ug/mL Thioridazinerespiration

0.031

Valinomycin0.5-10 uM Valinomycinrespiration

0.402

ZnSO42 mM ZnSO4respiration

-0.522

menadione6-10 ug/mL Menadionerespiration

0.771

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.801

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.443

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.749

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.395

NRP_1Non-replicating persistence stage 1dosRassociated

0.650

Amp0.2mg/mL AmpicillincellWall

0.190

Cephalexin20-100 ug/mL CephalexincellWall

-0.761

Cerulenin0.32-5 ug/mL CerulenincellWall

0.350

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.268

EMB10-20 ug/mL EthambutolcellWall

-0.258

Eta12-40 ug/mL EthionamidecellWall

0.091

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.222

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.386

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.729

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.416

BZA0.12 mg/mL BenzamidearomaticAmides

0.487

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.374

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.125

H2O24 mM hydrogen peroxideDNAdamaging

1.174

Levo10 ug/mL LevofloxacinDNAdamaging

0.772

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.698

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.288

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.240

UVUV-irradiationDNAdamaging

-1.839

ARP41-4 ug/mL Antitubercular compound ARP4?

0.694

Antimycin12.5-50 ug/mL Antimycin A?

-0.063

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.248

PA_110-50 ug/mL Antitubercular compound PA-1?

0.271

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.030

PA8240.2-2 ug/mL PA-824?

-1.911

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.075

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.586

Verapamil50 uM Verapamil?

0.726

mercaptoethanol2 mM 2-Mercaptoethanol?

0.672

methoxatin10-20 ug/mL Methoxatin?